Cascinu, Stefano <br/><br/>
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Jul 2011 
 - 37-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-010-1424-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--adverse effects<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--adverse effects<br/>Disease Progression<br/>Doxorubicin--adverse effects<br/>Female<br/>Fluorouracil--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Mitomycin--adverse effects<br/>Polyethylene Glycols--adverse effects<br/>Stomach<br/>Stomach Neoplasms--drug therapy<br/>Treatment Outcome